1 mg epinephrine
1 mg epinephrine: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Lead developer: ARS Pharmaceuticals, Inc. (SPRY)
Development Pipeline (1)
| Company | Phase |
|---|---|
| ARS Pharmaceuticals, Inc. (SPRY) | Phase 2 |
Clinical Trials (1)
An Outpatient, Randomized, Double-Blinded, Placebo-Controlled, Cross-Over Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria
Frequently asked questions
Who is developing 1 mg epinephrine?
1 mg epinephrine is being developed by ARS Pharmaceuticals, Inc..
How many clinical trials involve 1 mg epinephrine?
BioSniper tracks 1 clinical trial involving 1 mg epinephrine.
Analyze ARS Pharmaceuticals, Inc. & 1 mg epinephrine with AI
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company